BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• Press Releases

  Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion

  February 24, 2026

   · 

  20 min read
• Press Releases

  Slate Medicines Launches with $130 Million Series A Financing to Advance Anti-PACAP Therapies for the Prevention of Migraine and Other Headache Disorders

  February 24, 2026

   · 

  4 min read
• Press Releases

  Arrowhead Pharmaceuticals to Participate in Upcoming March 2026 Events

  February 24, 2026

   · 

  4 min read
• Press Releases

  Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A’TOMIC™) to our surgeons

  February 24, 2026

   · 

  6 min read
• Press Releases

  Siren Biotechnology Receives FDA Fast Track Designation for SRN-101 for the Treatment of Recurrent High-Grade Glioma

  February 24, 2026

   · 

  3 min read
• Press Releases

  Cellipont Bioservices and Soter Bio Announce Strategic Collaboration to Support Integrated U.S. Cell Therapy Manufacturing

  February 24, 2026

   · 

  4 min read
• Press Releases

  Respiree Strengthens Series A Syndicate to Advance Next-Generation Cardiorespiratory Care

  February 24, 2026

   · 

  2 min read
• Press Releases

  Olympus Announces Pediatric Use Indication for Two Single-Use Bronchoscopes

  February 24, 2026

   · 

  3 min read
• Press Releases

  Neurent Medical Announces Publication of Positive Randomized Controlled Trial Results for the NEUROMARK® System

  February 24, 2026

   · 

  3 min read
• Press Releases

  Jaguar Gene Therapy Announces Successful Completion of Dosing of First Patient Cohort in Clinical Trial Evaluating JAG201 for the Treatment of a Leading Monogenic Cause of Autism Spectrum Disorder Known as Phelan-McDermid Syndrome

  February 24, 2026

   · 

  11 min read